Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BLUECHIP.NS Stock Summary
Top 10 Correlated ETFs
BLUECHIP.NS
In the News
BLUECHIP.NS Financial details
Company Rating
Neutral
Market Cap
157.62M
Income
-20.76M
Revenue
256K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
30 May 2024
P/E
-7.14
Forward P/E
-
PEG
-0.1
P/S
-382.88
P/B
7.68
P/C
-
P/FCF
-
Quick Ratio
104
Current Ratio
43800
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.38
EPS next Y
-
EPS next Q
-
EPS this Y
-366.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-39.18%
Revenue Q/Q
2395.45%
EPS Q/Q
-200%
-
-
-
-
SMA20
-
SMA50
-
SMA100
200%
Inst Own
-
Inst Trans
-
ROA
-31%
ROE
-126%
ROC
-0.04%
Gross Margin
495%
Oper. Margin
1046%
Profit Margin
8626%
Payout
-
Shs Outstand
55.3M
Shs Float
41.27M
-
-
-
-
Target Price
-
52W Range
0.25-3.45
52W High
-
52W Low
-
RSI
30
Rel Volume
0.72
Avg Volume
80.93K
Volume
58.04K
Perf Week
-11.48%
Perf Month
0%
Perf Quarter
100%
Perf Half Y
80%
-
-
-
-
Beta
1.233
-
-
Volatility
0.1%, 0.22%
Prev Close
-1.82%
Price
2.7
Change
-1.82%
BLUECHIP.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0 | 0 | 0 | 0 | |
Net income per share | -0.07 | -0.23 | -0.05 | -0.04 | 0.12 | |
Operating cash flow per share | -0.01 | -0.49 | 0.31 | 0.5 | -0.1 | |
Free cash flow per share | -0.01 | -0.49 | 0.31 | 0.5 | -0.1 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0.1 | -0.03 | 0.23 | 0.7 | 0.87 | |
Tangible book value per share | 0.1 | -0.03 | 0.23 | 0.7 | 0.87 | |
Share holders equity per share | 0.1 | -0.03 | 0.23 | 0.7 | 0.87 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 30.42M | 5.53M | 8.96M | 22.12M | 19.36M | |
Enterprise value | 30.39M | 5.48M | 8.74M | 21.94M | 19.25M | |
P/E ratio | -7.78 | -0.44 | -3 | -8.89 | 2.81 | |
Price to sales ratio | 93.75 | -410.94 | 1.09K | 206.75 | 716.91 | |
POCF ratio | -79.81 | -0.21 | 0.49 | 0.8 | -3.48 | |
PFCF ratio | -79.81 | -0.21 | 0.49 | 0.8 | -3.48 | |
P/B Ratio | 5.67 | -2.88 | 0.65 | 0.57 | 0.4 | |
PTB ratio | 5.67 | -2.88 | 0.65 | 0.57 | 0.4 | |
EV to sales | 93.66 | -407.24 | 1.06K | 205.03 | 712.83 | |
Enterprise value over EBITDA | -8.81 | 0.91 | -2.98 | -8.82 | -7.84 | |
EV to operating cash flow | -79.74 | -0.2 | 0.48 | 0.8 | -3.46 | |
EV to free cash flow | -79.74 | -0.2 | 0.48 | 0.8 | -3.46 | |
Earnings yield | -0.13 | -2.26 | -0.33 | -0.11 | 0.36 | |
Free cash flow yield | -0.01 | -4.86 | 2.05 | 1.25 | -0.29 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.01 | -0.01 | 0.07 | 0.07 | 0.04 | |
Current ratio | 0.19 | 2 | 2.09 | 23.79 | 0.02 | |
Interest coverage | 120.12 | 625.04 | -58.78 | 1.24K | -501.5 | |
Income quality | 0.1 | 2.15 | -6.15 | -11.07 | -0.81 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.55 | -18.03 | 17.75 | 0.89 | 4.41 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.39 | 0.42 | 0.51 | 0.84 | 1.56 | |
ROIC | -0.71 | 2.94 | -0.21 | -0.06 | 0.01 | |
Return on tangible assets | -0.07 | -0.23 | -0.04 | -0.02 | 0.07 | |
Graham Net | -0.84 | -0.68 | -0.68 | -0.78 | -0.62 | |
Working capital | -43.24M | 507.12K | 618.64K | 24.49M | -45.72M | |
Tangible asset value | 5.33M | -1.93M | 13.86M | 38.72M | 47.91M | |
Net current asset value | -43.24M | -55.25M | -57.67M | -35.99M | -45.72M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 8.99M | 16.87M | 24.62M | 24.36M | 20.37M | |
Average payables | 1.88K | 802.5 | 0 | 0 | 500 | |
Average inventory | 63.32K | 63.32K | 63.32K | 63.16K | 63K | |
Days sales outstanding | 9.97K | -674.97K | 1.08M | 83.11K | 221.42K | |
Days payables outstanding | 0.4 | 0 | 0 | 0 | 0.33 | |
Days of inventory on hand | 15.88 | 22.12 | 18.92 | 11.5K | 20.81 | |
Receivables turnover | 0.04 | 0 | 0 | 0 | 0 | |
Payables turnover | 906.96 | 0 | 0 | 0 | 1.11K | |
Inventory turnover | 22.99 | 16.5 | 19.29 | 0.03 | 17.54 | |
ROE | -0.73 | 6.51 | -0.22 | -0.06 | 0.14 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | -0.01 | 0 | 0 | 0.01 | |
Net income per share | -0.01 | 0.15 | -0.53 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 1.72 | 0.82 | 0.87 | 0.36 | 0 | |
Tangible book value per share | 0 | 0.82 | 0 | 0.36 | 0 | |
Share holders equity per share | 1.72 | 0.82 | 0.87 | 0.36 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 10.05M | 20.56M | 47.01M | 77.43M | 138.26M | |
Enterprise value | 10.15M | 20.45M | 47.12M | 77.32M | 138.26M | |
P/E ratio | -7.5 | 0.6 | -0.4 | -91.3 | 163.04 | |
Price to sales ratio | 218.48 | -65.28 | 0 | 3.52K | 251.84 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.17 | 0.43 | 0.98 | 3.91 | 0 | |
PTB ratio | 0.17 | 0.43 | 0.98 | 3.91 | 0 | |
EV to sales | 220.74 | -64.93 | 0 | 3.51K | 251.84 | |
Enterprise value over EBITDA | -30.31 | -26.77 | 1.75 | -261.22 | 652.17 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.03 | 0.42 | -0.62 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.31 | 0.14 | 0 | 0.35 | 0 | |
Current ratio | 0 | 0.02 | 0 | 43.8K | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | -0.72 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | -0.12 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.62 | 1.64 | 3.22 | 0.18 | 0 | |
ROIC | 0 | 0.43 | -0.05 | -0.01 | 0 | |
Return on tangible assets | 0 | 0.09 | 0 | 0 | 0 | |
Graham Net | 0 | -0.59 | 0 | -0.51 | 0 | |
Working capital | 104K | -45.72M | 110K | 43.8M | 0 | |
Tangible asset value | 0 | 47.91M | 0 | 28.23M | 0 | |
Net current asset value | 104K | -45.72M | 110K | -4.37M | 0 | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 8.19M | 8.19M | 13.11M | 13.11M | |
Average payables | 0 | 500 | 500 | 500 | 500 | |
Average inventory | 31.5K | 31.5K | 31.5K | 31.5K | 31.5K | |
Days sales outstanding | 0 | -4.68K | 0 | 107.29K | 0 | |
Days payables outstanding | 0 | 0.39 | 0 | 0.4 | 0 | |
Days of inventory on hand | 0 | 24.87 | 0 | 24.98 | 0 | |
Receivables turnover | 0 | -0.02 | 0 | 0 | 0 | |
Payables turnover | 0 | 228 | 0 | 227 | 0 | |
Inventory turnover | 0 | 3.62 | 0 | 3.6 | 0 | |
ROE | -0.01 | 0.18 | -0.61 | -0.01 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
BLUECHIP.NS Frequently Asked Questions
What is Blue Chip India Limited stock symbol ?
Blue Chip India Limited is a IN stock and trading under the symbol BLUECHIP.NS
What is Blue Chip India Limited stock quote today ?
Blue Chip India Limited stock price is $2.7 today.
Is Blue Chip India Limited stock public?
Yes, Blue Chip India Limited is a publicly traded company.